Sarepta Therapeutics (Brazil) Probability of Future Stock Price Finishing Over 39.28
| S1RP34 Stock | BRL 40.47 1.74 4.12% |
Sarepta |
Sarepta Therapeutics Target Price Odds to finish over 39.28
The tendency of Sarepta Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay above R$ 39.28 in 90 days |
| 40.47 | 90 days | 39.28 | under 4 |
Based on a normal probability distribution, the odds of Sarepta Therapeutics to stay above R$ 39.28 in 90 days from now is under 4 (This Sarepta Therapeutics probability density function shows the probability of Sarepta Stock to fall within a particular range of prices over 90 days) . Probability of Sarepta Therapeutics price to stay between R$ 39.28 and its current price of R$40.47 at the end of the 90-day period is roughly 2.82 .
Assuming the 90 days trading horizon Sarepta Therapeutics has a beta of -0.25. This usually implies as returns on the benchmark increase, returns on holding Sarepta Therapeutics are expected to decrease at a much lower rate. During a bear market, however, Sarepta Therapeutics is likely to outperform the market. Additionally Sarepta Therapeutics has an alpha of 0.1482, implying that it can generate a 0.15 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Sarepta Therapeutics Price Density |
| Price |
Predictive Modules for Sarepta Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Sarepta Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sarepta Therapeutics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Sarepta Therapeutics is not an exception. The market had few large corrections towards the Sarepta Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Sarepta Therapeutics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Sarepta Therapeutics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.15 | |
β | Beta against Dow Jones | -0.25 | |
σ | Overall volatility | 2.17 | |
Ir | Information ratio | -0.0032 |
Sarepta Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Sarepta Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Sarepta Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Sarepta Therapeutics had very high historical volatility over the last 90 days | |
| The company reported the revenue of 701.89 M. Net Loss for the year was (418.78 M) with loss before overhead, payroll, taxes, and interest of (165.84 M). | |
| Sarepta Therapeutics has accumulated about 1.74 B in cash with (443.17 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 21.78. |
Sarepta Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Sarepta Stock often depends not only on the future outlook of the current and potential Sarepta Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Sarepta Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 87.1 M |
Sarepta Therapeutics Technical Analysis
Sarepta Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Sarepta Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Sarepta Therapeutics. In general, you should focus on analyzing Sarepta Stock price patterns and their correlations with different microeconomic environments and drivers.
Sarepta Therapeutics Predictive Forecast Models
Sarepta Therapeutics' time-series forecasting models is one of many Sarepta Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Sarepta Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Sarepta Therapeutics
Checking the ongoing alerts about Sarepta Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Sarepta Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Sarepta Therapeutics had very high historical volatility over the last 90 days | |
| The company reported the revenue of 701.89 M. Net Loss for the year was (418.78 M) with loss before overhead, payroll, taxes, and interest of (165.84 M). | |
| Sarepta Therapeutics has accumulated about 1.74 B in cash with (443.17 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 21.78. |
Additional Information and Resources on Investing in Sarepta Stock
When determining whether Sarepta Therapeutics is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Sarepta Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Sarepta Therapeutics Stock. Highlighted below are key reports to facilitate an investment decision about Sarepta Therapeutics Stock:Check out Sarepta Therapeutics Backtesting, Sarepta Therapeutics Valuation, Sarepta Therapeutics Correlation, Sarepta Therapeutics Hype Analysis, Sarepta Therapeutics Volatility, Sarepta Therapeutics History as well as Sarepta Therapeutics Performance. For information on how to trade Sarepta Stock refer to our How to Trade Sarepta Stock guide.You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.